| scholarly article | Q13442814 |
| P50 | author | Darwin Prockop | Q25028599 |
| Armand Keating | Q60396073 | ||
| Donald G Phinney | Q67257671 | ||
| P2093 | author name string | Darwin J. Prockop | |
| Katarina Le Blanc | |||
| Malcolm Brenner | |||
| Luc Sensebe | |||
| Edwin Horwitz | |||
| Willem E. Fibbe | |||
| Paul J. Simmons | |||
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| Persistent use of "false" cell lines | Q28254701 | ||
| Human iPS cell derivation/reprogramming | Q33402979 | ||
| Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms | Q33713663 | ||
| Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors | Q37053150 | ||
| Long-term in vitro expansion alters the biology of adult mesenchymal stem cells | Q37269767 | ||
| Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. | Q40348177 | ||
| Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen | Q41272620 | ||
| Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate | Q45863683 | ||
| Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes | Q46069224 | ||
| Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. | Q53301733 | ||
| Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. | Q53328521 | ||
| Spontaneous human adult stem cell transformation. | Q53358878 | ||
| Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. | Q53390457 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dysplasia | Q1128996 |
| P304 | page(s) | 576-578 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Cytotherapy | Q5201399 |
| P1476 | title | Defining the risks of mesenchymal stromal cell therapy | |
| P478 | volume | 12 |
| Q90290608 | A Comparison of Phenotypic and Functional Properties of Mesenchymal Stromal Cells and Multipotent Adult Progenitor Cells |
| Q38664590 | A discussion on adult mesenchymal stem cells for drug delivery: pros and cons |
| Q36411255 | A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. |
| Q34979619 | A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression |
| Q41882050 | A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells |
| Q40185923 | A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients |
| Q37590912 | Adipose-Derived Mesenchymal Stem Cells for Treatment of Airway Injuries in A Patient after Long-Term Exposure to Sulfur Mustard |
| Q39035161 | Adoptive cell transfer in autoimmune hepatitis |
| Q37622055 | Adult human mesenchymal stromal cells and the treatment of graft versus host disease |
| Q37711784 | Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta |
| Q40278917 | Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial |
| Q41638176 | Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis |
| Q53171235 | Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. |
| Q41672120 | Application of adipose-derived stromal cells in fat grafting: Basic science and literature review |
| Q98513776 | Articular cartilage regeneration by activated skeletal stem cells |
| Q26776414 | Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review |
| Q37830375 | Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation |
| Q36456715 | CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα |
| Q95328824 | Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice |
| Q47619959 | Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases |
| Q92983782 | Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis |
| Q91891770 | Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells |
| Q21198864 | Clinical applications of mesenchymal stem cells |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q45887603 | Combined cell-gene therapy for lung cancer: rationale, challenges and prospects. |
| Q37857084 | Concise review: Adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation |
| Q37056276 | Concise review: mesenchymal stem cells and translational medicine: emerging issues. |
| Q34747451 | Current concepts: the role of mesenchymal stem cells in the management of knee osteoarthritis. |
| Q43984170 | Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders. |
| Q92712147 | Dental Pulp Stem Cells: An Attractive Alternative for Cell Therapy in Ischemic Stroke |
| Q86054192 | Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial |
| Q35168406 | Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration |
| Q42672137 | Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial |
| Q52722969 | Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. |
| Q37686456 | First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial |
| Q42360160 | Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells |
| Q28071840 | Genetically modified mesenchymal stromal cells in cancer therapy |
| Q47294906 | Globose basal cells for spinal cord regeneration |
| Q35660316 | HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice |
| Q50100353 | Historical Overview of Stem Cell Biology and Fat Grafting |
| Q36141205 | How mesenchymal stem cells interact with tissue immune responses |
| Q36045296 | Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis |
| Q37414261 | Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells |
| Q45234474 | Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium |
| Q34480369 | Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy |
| Q37604317 | Human-derived normal mesenchymal stem/stromal cells in anticancer therapies |
| Q64930590 | Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. |
| Q26822818 | Immunomodulation by mesenchymal stem cells in veterinary species |
| Q47120595 | Impact of Age on Human Adipose Stem Cells for Bone Tissue Engineering |
| Q42055619 | Impact of age on human adipose stem cells for bone tissue engineering |
| Q37999382 | Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies |
| Q26748907 | Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury |
| Q40974084 | Interactome and reciprocal activation of pathways in topical mesenchymal stem cells and the recipient cerebral cortex following traumatic brain injury |
| Q93377427 | Intra-articular treatment options for knee osteoarthritis |
| Q53608103 | Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis. |
| Q39705167 | Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. |
| Q36130979 | Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis |
| Q37431827 | Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells |
| Q94550219 | Irradiation induces cancer lung metastasis through activation of the cGAS-STING-CCL5 pathway in mesenchymal stromal cells |
| Q54388224 | Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cel |
| Q38099034 | Large-scale production of human mesenchymal stem cells for clinical applications. |
| Q27025291 | Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations |
| Q61818598 | Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy |
| Q38395222 | Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives |
| Q97420853 | Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation? |
| Q58766184 | Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering |
| Q98944107 | Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury |
| Q38167714 | Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine |
| Q35153085 | Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1. |
| Q37891375 | Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases |
| Q37822321 | Mesenchymal stem cells in the pathogenesis and therapy of breast cancer |
| Q37196614 | Mesenchymal stem cells in tissue repairing and regeneration: Progress and future |
| Q37287511 | Mesenchymal stem cells with irreversibly arrested proliferation stimulate decidua development in rats |
| Q34422955 | Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. |
| Q35665181 | Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation |
| Q47694971 | Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion |
| Q57254134 | Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study |
| Q38733373 | Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit |
| Q47124715 | Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death |
| Q40567182 | Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model |
| Q37970019 | Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis |
| Q38499617 | Mesenchymal stromal cells to halt the progression of type 1 diabetes? |
| Q47147916 | Metabolic profiles of adipose-derived and bone marrow-derived stromal cells from elderly coronary heart disease patients by capillary liquid chromatography quadrupole time-of-flight mass spectrometry |
| Q91925965 | Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol |
| Q27005588 | New approaches to radiation protection |
| Q33722575 | Placental Stromal Cell Therapy for Experimental Autoimmune Encephalomyelitis: The Role of Route of Cell Delivery |
| Q28079361 | Plastic Surgery Challenges in War Wounded II: Regenerative Medicine |
| Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
| Q42242005 | Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of activ |
| Q37585445 | Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience |
| Q30590258 | Primary progressive multiple sclerosis: progress and challenges. |
| Q46035036 | Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice. |
| Q38282065 | Rationale for the potential use of mesenchymal stromal cells in liver transplantation |
| Q64244050 | Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus |
| Q39266167 | Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress. |
| Q37885846 | Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases |
| Q34469147 | Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials |
| Q91761207 | Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study |
| Q50088392 | Sphingosine-1-phosphate mediates the therapeutic effects of bone marrow mesenchymal stem cell-derived microvesicles on articular cartilage defect |
| Q26770087 | Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview |
| Q46013546 | Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in mice. |
| Q48450832 | Stem cell therapy in multiple sclerosis: a future perspective |
| Q47765179 | Stem cell therapy in necrotizing enterocolitis: Current state and future directions |
| Q39454392 | Stem cell therapy in osteoarthritis: a step too far? |
| Q38472909 | Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta? |
| Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
| Q36014064 | Stem cells and regenerative medicine in lung biology and diseases. |
| Q33887466 | Stem cells in the face: tooth regeneration and beyond |
| Q37651549 | Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. |
| Q50771347 | Stem cells. U.S. regulation of stem cells as medical products |
| Q39452218 | Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration. |
| Q38696262 | Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis |
| Q35588483 | Systematic review and meta-analysis of efficacy of mesenchymal stem cells on locomotor recovery in animal models of traumatic brain injury. |
| Q36292319 | Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy. |
| Q55155674 | Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight. |
| Q36454721 | TNF-α and IL-1β-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor |
| Q38888000 | TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke |
| Q38042089 | Tendon regeneration in human and equine athletes: Ubi Sumus-Quo Vadimus (where are we and where are we going to)? |
| Q33815233 | The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells |
| Q38210142 | The current landscape of adipose-derived stem cells in clinical applications |
| Q36096318 | Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice. |
| Q92733083 | Thrombin Preconditioning Boosts Biogenesis of Extracellular Vesicles from Mesenchymal Stem Cells and Enriches Their Cargo Contents via Protease-Activated Receptor-Mediated Signaling Pathways |
| Q34599502 | Tissue engineering of rat bladder using marrow-derived mesenchymal stem cells and bladder acellular matrix |
| Q33656032 | Transdifferentiation of autologous bone marrow cells on a collagen-poly(ε-caprolactone) scaffold for tissue engineering in complete lack of native urothelium. |
| Q34557484 | Translating research into clinical scale manufacturing of mesenchymal stromal cells |
| Q37553721 | Transplantation of human umbilical cord mesenchymal stem cells in cochlea to repair sensorineural hearing |
| Q47155691 | Treatment with Allogenic Mesenchymal Stromal Cells in a Murine Model of Systemic Lupus Erythematosus |
| Q35190404 | Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia. |
| Q38730790 | Use of genetically engineered stem cells for glioma therapy |
| Q47435681 | Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury. |
| Q34985947 | Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects. |
| Q53074101 | Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. |
| Q83514683 | [Mesenchymal stromal cells: Biological properties and clinical prospects] |
Search more.